BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8691961)

  • 1. Alzheimer's disease, Down's syndrome, and chromosome segregation.
    Potter H; Geller LN
    Lancet; 1996 Jul; 348(9019):66. PubMed ID: 8691961
    [No Abstract]   [Full Text] [Related]  

  • 2. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.
    Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ
    Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E, Alzheimer's disease and Down's syndrome.
    Prasher VP; Haque MS
    Br J Psychiatry; 2000 Nov; 177():469-70. PubMed ID: 11060007
    [No Abstract]   [Full Text] [Related]  

  • 4. Lower frequency of apolipoprotein E4 allele in an "elderly" Down's syndrome population.
    Cosgrave M; Tyrrell J; Dreja H; Hawi Z; Lawlor BA; Gill M
    Biol Psychiatry; 1996 Oct; 40(8):811-3. PubMed ID: 8894078
    [No Abstract]   [Full Text] [Related]  

  • 5. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome.
    Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B
    Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
    Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
    Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.
    Saunders AM; Schmader K; Breitner JC; Benson MD; Brown WT; Goldfarb L; Goldgaber D; Manwaring MG; Szymanski MH; McCown N
    Lancet; 1993 Sep; 342(8873):710-1. PubMed ID: 8103823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE genotype and Down's syndrome.
    Hardy J; Crook R; Perry R; Raghavan R; Roberts G
    Lancet; 1994 Apr; 343(8903):979-80. PubMed ID: 7909036
    [No Abstract]   [Full Text] [Related]  

  • 11. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
    van Gool WA; Evenhuis HM; van Duijn CM
    Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome.
    Sekijima Y; Ikeda S; Tokuda T; Satoh S; Hidaka H; Hidaka E; Ishikawa M; Yanagisawa N
    Eur Neurol; 1998; 39(4):234-7. PubMed ID: 9635475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the APOE alleles impact in Down's syndrome.
    Lambert JC; Pérez-Tur J; Dupire MJ; Delacourte A; Frigard B; Chartier-Harlin MC
    Neurosci Lett; 1996 Dec; 220(1):57-60. PubMed ID: 8977148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down's syndrome and Alzheimer's disease: towards secondary prevention.
    Ness S; Rafii M; Aisen P; Krams M; Silverman W; Manji H
    Nat Rev Drug Discov; 2012 Sep; 11(9):655-6. PubMed ID: 22935789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E allele distribution in parents of Down's syndrome children.
    Avramopoulos D; Mikkelsen M; Vassilopoulos D; Grigoriadou M; Petersen MB
    Lancet; 1996 Mar; 347(9005):862-5. PubMed ID: 8622392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between Down's syndrome and Alzheimer's disease: 1.
    Soliman A; Hawkins D
    Br J Nurs; 1998 Jul 9-22; 7(13):779-84. PubMed ID: 9732570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The apolipoprotein E genotype and Down's syndrome].
    Rascón Trincado MV; González Sarmiento R; Salazar A-Villalobos V
    Rev Clin Esp; 1997 Oct; 197(10):680-3. PubMed ID: 9424665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome.
    Schupf N; Kapell D; Lee JH; Zigman W; Canto B; Tycko B; Mayeux R
    Ann Neurol; 1996 Nov; 40(5):799-801. PubMed ID: 8957023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease.
    Geller LN; Potter H
    Neurobiol Dis; 1999 Jun; 6(3):167-79. PubMed ID: 10408806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.